These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15591298)

  • 1. Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women.
    Szymanski LM; Kessler CM; Fernhall B
    J Appl Physiol (1985); 2005 Apr; 98(4):1341-8. PubMed ID: 15591298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy.
    Stauffer BL; Hoetzer GL; Smith DT; DeSouza CA
    J Appl Physiol (1985); 2004 Jan; 96(1):143-8. PubMed ID: 12949021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy, inflammation, and hemostasis in elderly women.
    Cushman M; Meilahn EN; Psaty BM; Kuller LH; Dobs AS; Tracy RP
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):893-9. PubMed ID: 10195915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
    Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
    Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
    Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
    Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies.
    Acs N; Vajo Z; Miklos Z; Siklosi G; Paulin F; Felicetta JV; Székåcs B
    Gynecol Endocrinol; 2002 Aug; 16(4):335-46. PubMed ID: 12396563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen.
    Kalela A; Jokela H; Lehtimäki T; Uppa H; Kunnas T; Teisala K; Punnonen R; Nikkari ST
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):217-20. PubMed ID: 16337074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
    Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
    Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
    Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
    Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
    Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
    Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
    Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
    Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.
    Du Y; Melchert HU; Schäfer-Korting M
    Maturitas; 2005; 52(3-4):223-34. PubMed ID: 16040212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status.
    DeSouza CA; Stevenson ET; Davy KP; Jones PP; Seals DR
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M294-8. PubMed ID: 9310083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy.
    Estellés A; Cano A; Falcó C; España F; Gilabert J; Grancha S; Aznar J
    Thromb Haemost; 1999 Jan; 81(1):104-10. PubMed ID: 10348700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.